glp 1 and afib Glucagon‐like peptide‐1 receptor agonist semaglutide reduces atrial fibrillation incidence: A systematic review meta‐analysis - Saglietto - 2024 - European Journal of Clinical Investigation GLP-1 RECEPTOR AGONISTS AND ATRIAL
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 23.Mann JFE, et al
E.WoelnerhanssenB.PetersT.Christoffel-CourtinC.GassM.et al
Book your virtual consultation with Pure Med Spa today
Another approved use for Victoza is to reduce the risk of major cardiovascular disease, like heart attack or stroke, in adults with type 2 diabetes with known heart disease
Andrews CN, et al
Nisha Dahiya +2 more Table of Contents Glucagon-like peptide-1 (GLP-1) medications are gaining popularity for their benefits for type-2-diabetes and weight management 1
